← All trials
NCT01057680
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2010
- Primary completion
- Feb 29, 2012
- Completion date
- Feb 29, 2012
- First posted
- Jan 27, 2010
- Last posted
- Dec 27, 2012
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of SaskatchewanLead sponsor
- University of ReginaOverall official - principal investigator
- University of SaskatchewanOverall official - principal investigator
- University of SaskatchewanReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.